Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable way to predict who will develop it or when. Unlike conditions such as coronary ...
Sept. 17, 2025 — Barbara Riegel, Ph.D., R.N., FAHA, Emerita Edith Clemmer Steinbright Professor of Gerontology at the ...
Sept. 16, 2025 — PaceMate has appointed Sean Shoffstall as Head of AI, Innovation and Data Strategy. Shoffstall joins ...
Sept. 11, 2025 — Newswise — A new Mayo Clinic study finds that many heart attacks in people under 65 — especially women ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating ...

Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable ...
Sept. 2, 2025 — Although cardiovascular disease is a leading cause of death for women, they remain underrepresented in ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Sept. 9, 2025 — The John Ritter Foundation for Aortic Health has released an updated Ritter Rules, a set of clear ...
Sept. 9, 2025 — The American Venous Forum (AVF), International Society on Thrombosis and Haemostasis (ISTH), National ...
Sept. 2, 2025 — GE HealthCare recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Sept. 04, 2025 — CorVista Health has published a new case series in the Journal of the American College of Cardiology ...
Sept. 9, 2025 — Neurescue ApS has received CE Mark approval for its Neurescue device, a medical device approved to treat ...
Sept. 8, 2025 — GE HealthCare recently announced a Distribution and Services Agreement (DSA) with CardioNavix, a part of ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Sept. 8, 2025 — Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation ...
Sept. 8, 2025 — AMO Pharma Ltd., a clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders ...
Sept. 5, 2025 — Idorsia Ltd has announced a first-of-its-kind initiative with the Stanford Hypertension Center and Duke ...